CClinicalTrials.gg
CompletedNCT06168253Updated Feb 24, 2025

Text Message Safety Behavior Fading for Social Anxiety

An interventional study of Safety Behavior Fading for Social Anxiety and Unhealthy Behavior Fading in Social Anxiety, sponsored by Florida State University. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-02-24.

Sponsored by Florida State University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
201
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The current study aims to explore the efficacy of a text message based Safety Behavior Fading Intervention compared to an active control intervention.

Read the detailed description

Safety behavior fading may be a viable standalone intervention for social anxiety. In the present trial, participants high in social anxiety will be randomized to either receive a daily checklist exercise aimed at eliminating (1) safety behaviors or (2) unhealthy behaviors. Individuals randomly assigned to the safety behavior fading condition will receive instructions to decrease or eliminate their four most habitual social anxiety safety behaviors. In addition, they will receive daily reminders via text message to decrease these behaviors, along with a safety behavior monitoring checklist in which the participant indicates the extent to which they decreased and/or eliminated each safety behavior over the previous day. Individuals randomly assigned to the control condition will receive similar text messages and a daily checklist to encourage fading of unhealthy behaviors. Participants in both conditions will complete checklists for 28 days. After day 14 of treatment, participants will re-select their target safety behaviors or unhealthy behaviors, and will then be prompted to reduce these new behaviors for another 14 days.

02

Conditions studied

  • Social Anxiety

Browse trials for

Keywords

  • Social Anxiety
  • Safety Behaviors
  • Intervention
  • Text-message
03

In context

Anxiety Disorders

4,868 studies on the registry are indexed under Anxiety Disorders; 1,390 are open to participants now.

This study's enrollment of 201 is above the median of 80 across 4,174 interventional studies indexed under Anxiety Disorders.

Browse Anxiety Disorders studies →

Lead sponsor

Florida State University is the lead sponsor of 241 studies on the registry; 46 are open to participants now.

Of its 15 completed or terminated interventional studies of FDA-regulated products, 9 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Social Phobia Inventory Score >29
  • Stable Psychotropic Medications for 4 weeks prior to participation

Exclusion criteria

Exclusion Criteria:

  • Currently participating in psychotherapy for social anxiety
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
201 participants (actual)

Study arms

  • Experimental
    Experimental: Safety Behavior Fading

    This treatment lasts a total of 28 days. Participants will be asked to identify common safety behaviors related to social anxiety. For the next 14 days, participants will receive instructions to fade out these behaviors. After 14 days, participants will be asked to re-select their target safety behaviors and continue to reduce them over the next two weeks.

    Behavioral: Safety Behavior Fading for Social Anxiety

  • Active comparator
    Unhealthy Behavior Fading

    This treatment lasts a total of 28 days. Participants will be asked to identify common unhealthy behaviors related to social anxiety. For the next 14 days, participants will receive instructions to fade out these behaviors. After 14 days, participants will be asked to re-select their target unhealthy behaviors and continue to reduce them over the next two weeks.

    Behavioral: Unhealthy Behavior Fading

Interventions

  • BehavioralSafety Behavior Fading for Social Anxiety

    Participants are asked to reduce or eliminate safety behaviors via text message reminders and checklists to monitor progress.

  • BehavioralUnhealthy Behavior Fading

    Participants are asked to reduce or eliminate unhealthy behaviors via text message reminders and checklists to monitor progress.

06

What researchers measure

Primary outcomes

  1. Change in Social Phobia Inventory (SPIN)

    Self-report scale that measures Social anxiety symptoms. Scores range from 0 to 68 with higher scores indicating higher levels of social anxiety symptoms.

    Time frame: Time Frame: Day 0, Day 14, Day 28, Day 56

Secondary outcomes

  1. Change in Center For Epidemiological Studies Depression Scale, Ten Item Version (CESD-10)

    A 10-item self-report scale measuring depression symptoms; higher scores indicate greater depressive symptoms.

    Time frame: Time Frame: Day 0, Day 28, Day 56

  2. Change in UCLA Loneliness Scale, Short Form (ULS-8)

    An 8-item self-report measure of subjective loneliness, with higher scores indicating greater loneliness.

    Time frame: Time Frame: Day 0, Day 28, Day 56

  3. Change in Self-Beliefs Related to Social Anxiety Scale (SBSA)

    A 15-item scale measuring common and generally maladaptive beliefs related to social anxiety.

    Time frame: Time Frame: Day 0, Day 28, Day 56

  4. Change in Subtle Avoidance Frequency Examination (SAFE) scale

    A 32-item self-report measure of safety behavior usage frequency

    Time frame: Time Frame: Day 0, Day 28, Day 56

07

Study locations

1 site
  • Florida State University
    Tallahassee, Florida 32312, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 24, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06168253
Lead sponsor
Florida State University
Responsible party
Jesse Cougle (Principal Investigator, Florida State University) — Principal investigator
First posted
Dec 13, 2023
Start date
Jan 1, 2024
Primary completion
Sep 1, 2024
Completion
Sep 1, 2024
Last update
Feb 24, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion